Search Results 961-970 of 18614 for autoimmune hepatitis

  1. Publications - Joseph A. Murray, M.D. - Mayo Clinic

    ... autoimmune diseases. Scand J Gastroenterol. 2023 Jul-Dec; 58 (12):1398-1404 Epub 2023 July 06. View PubMed; Behl S, Khan MR, Ismail Y, Swantek C, Chen ZE ...

  2. An Expanded Access Study of Sofosbuvir Combined with Ribavirin and Either with or without Pegylated Interferon for Treating Aggressive Post-Transplant Hepatitis C - Mayo Clinic

    Patients who have an aggressive, recurring hepatitis C infection following liver transplant, will be given sofosbuvir combined with ribavirin, and pegylated ...

  3. Hepatopulmonary syndrome - Doctors and departments - Mayo Clinic

    This lung condition causes low oxygen levels and shortness of breath in people who have advanced liver disease.

  4. Cold urticaria - Symptoms & causes - Mayo Clinic

    A less common type — secondary acquired cold urticaria — can be caused by an underlying health problem, such as hepatitis or cancer. You have certain ...

  5. Ataxia - Symptoms and causes - Mayo Clinic

    This may be either due to a blood vessel blockage or bleeding on the brain. Multiple sclerosis. This condition may cause ataxia. Autoimmune diseases. Several ...

  6. Tetracaine and oxymetazoline (nasal route) - Mayo Clinic

    Trouble swallowing—Use with caution. May make these conditions worse. Liver disease, severe or; Pseudocholinesterase deficiency (a genetic disease)—Use with ...

  7. Publications - Liu Yang, M.B.B.S. - Mayo Clinic

    Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. ... liver disease. Gastroenterology.

  8. Hepatobiliary and Pancreas Surgery - Conditions treated - Mayo Clinic

    Autoimmune pancreatitis; Bile duct cyst; Bile duct injury; Bile duct ... Polycystic liver disease; Pseudomyxoma peritonei; Recurrent cancer; Retroperitoneal ...

  9. Zolpidem (oral route) - Mayo Clinic

    Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Liver disease, mild to moderate—Use of ...

  10. Difelikefalin (intravenous route) - Mayo Clinic

    Liver disease, mild to moderate—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Liver disease, severe or ...